Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2005.053363v1, 2005; 10.1373/clinchem.2005.053363
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2005.053363v1
51/12/2348    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Herrmann, M.
Right arrow Articles by Herrmann, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Herrmann, M.
Right arrow Articles by Herrmann, W.

Received on April 27, 2005
Accepted on September 6, 2005

Other Areas of Clinical Chemistry

Increased Osteoclast Activity in the Presence of Increased Homocysteine Concentrations

Markus Herrmann 1, Thomas Widmann 2, Graziana Colaianni 3, Silvia Colucci 3, Alberta Zallone 3, Wolfgang Herrmann 1*

1 Abteilung für Klinische Chemie und Laboratoriumsmedizin/Zentrallabor, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany
2 Klinik für Innere Medizin I, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany
3 Department of Human Anatomy and Histology, University of Bari, Bari, Italy

* To whom correspondence should be addressed. E-mail: kchwher{at}uniklinik-saarland.de.

Background: Increased plasma homocysteine (HCY) may be an independent risk factor for osteoporotic fractures and therefore may also adversely affect bone metabolism. We analyzed the effect of HCY on human osteoclast (OC) activity.

Methods: We cultured peripheral blood mononuclear cells from 17 healthy male donors [median (SD) age, 30 (5) years] for 20 days with 25 µg/L macrophage-colony-stimulating factor (days 0-6), 20 µg/L receptor-activator of nuclear factor-{kappa}B ligand (days 6-20), and 4 different concentrations of HCY (0, 10, 50, and 100 µmol/L; days 0-20). For control purposes, cysteine and glutathione were tested in equimolar concentrations. OCs were identified as large, multinucleated cells with tartrate-resistant acid phosphatase (TRAP) activity and surface vitronectin receptors. We quantified OC activity by measuring TRAP activity. We analyzed cathepsin K (CP-K) activity in 9 donor samples and estimated the dentine-resorbing activity on standard dentine slices in 3 samples.

Results: After 20 days of culture, most cells were fully differentiated OCs. TRAP activity increased with increasing HCY concentrations (P <0.001). HCY concentrations of 10, 50, and 100 µmol/L stimulated TRAP activity by 20%, 15%, and 42%. Additionally, HCY stimulated CP-K activity (P = 0.005): in the presence of 100 µmol/L HCY, CP-K activity was ~38% higher than in controls (P = 0.002). Bone-resorbing activity was significantly increased in cultures with 50 and 100 µmol/L HCY. Cysteine and glutathione significantly decreased TRAP and CP-K activity.

Conclusions: Increased HCY concentrations specifically stimulate OC activity in vitro, suggesting a mechanistic role of HCY for bone resorption. Future studies clarifying the mechanistic role of increased HCY concentrations in osteoporosis could have interesting therapeutic implications.




The following articles in journals at HighWire Press have cited this article:


Home page
Am. J. Clin. Nutr.Home page
J. H Holstein, M. Herrmann, C. Splett, W. Herrmann, P. Garcia, T. Histing, S. Graeber, M. F. Ong, K. Kurz, T. Siebel, et al.
Low serum folate and vitamin B-6 are associated with an altered cancellous bone structure in humans
Am. J. Clinical Nutrition, November 1, 2009; 90(5): 1440 - 1445.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
H. Refsum, E. Nurk, A. D. Smith, P. M. Ueland, C. G. Gjesdal, I. Bjelland, A. Tverdal, G. S. Tell, O. Nygard, and S. E. Vollset
The Hordaland Homocysteine Study: A Community-Based Study of Homocysteine, Its Determinants, and Associations with Disease
J. Nutr., June 1, 2006; 136(6): 1731S - 1740S.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2005 by the American Association for Clinical Chemistry.